Analysts Set Trupanion, Inc. (NASDAQ:TRUP) PT at $45.33

Shares of Trupanion, Inc. (NASDAQ:TRUP) have received an average recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $45.33.

TRUP has been the topic of several research reports. Stifel Nicolaus upped their price objective on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a report on Monday, January 6th. Bank of America upped their price objective on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday, September 20th. Northland Securities boosted their target price on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Finally, Piper Sandler boosted their target price on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st.

Trupanion Price Performance

TRUP stock opened at $43.95 on Wednesday. The firm has a market cap of $1.86 billion, a price-to-earnings ratio of -137.34 and a beta of 1.61. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion has a 12-month low of $19.69 and a 12-month high of $57.90. The company’s fifty day simple moving average is $51.43 and its 200 day simple moving average is $44.85.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The firm had revenue of $327.50 million for the quarter, compared to analyst estimates of $321.79 million. During the same quarter in the prior year, the business earned ($0.10) earnings per share. The business’s quarterly revenue was up 14.6% compared to the same quarter last year. On average, analysts expect that Trupanion will post -0.23 earnings per share for the current year.

Insider Transactions at Trupanion

In other Trupanion news, Director Murray B. Low sold 2,000 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the completion of the sale, the director now directly owns 131,513 shares of the company’s stock, valued at approximately $6,926,789.71. This represents a 1.50 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 9,867 shares of the company’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. Insiders sold a total of 28,597 shares of company stock valued at $1,522,082 over the last three months. Corporate insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. FMR LLC boosted its stake in Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after acquiring an additional 1,170,202 shares during the last quarter. Renaissance Technologies LLC purchased a new position in Trupanion in the second quarter valued at about $4,739,000. Marshall Wace LLP boosted its stake in Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after acquiring an additional 116,496 shares during the last quarter. Connors Investor Services Inc. boosted its stake in Trupanion by 31.3% in the second quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock valued at $3,339,000 after acquiring an additional 27,042 shares during the last quarter. Finally, Dalton Investments Inc. purchased a new position in Trupanion in the second quarter valued at about $1,029,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.